NorthWest Biotherapeutics Inc (NWBO)

[Maverick0408]

I have said all along no MHRA approval until Q1 2023 at best. And no reimbursements until Q2 2023. Again, these are best case scenarios and things may slip if commercial production certification gets delayed due to non compliance and back and forth with the auditors.

Time and again, we have seen that this management is not proactive and lack the experience and foresight. I don’t see an aggressive go-to market strategy/plan from this team! As a consequence, we will remain a boutique shop even after approvals and reimbursements. We really need a major partner or buyout that can take the reins away from this group. If one of these scenarios do not occur soon, I’d be quite concerned.